Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zibotentan/dapagliflozin in cirrhosis
NCT06269484Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of zibotentan in Liver cirrhosis (LC), sponsored by AstraZeneca. Started Feb 2024; status: completed.
02
Drugs
zibotentan
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT06269484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06269484.